Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Matritech (NASDAQ - NMPS) -- Ignore unavailable to you. Want to Upgrade?

To: Wesley0428 who wrote (523)	12/22/1997 7:04:00 PM
From: John McCarthy	Respond to of 849

Wesley0428 - Thanks! for mentioning it. If I could generalize your thoughts - IMII's microscopic test system and Bayer's options with it move Bayer into a higher, faster gear. End user product may result quicker than otherwise. As a consequence, NMPS tech. may or may not be of more importance to Bayer and therefore, come into play quicker than otherwise. Great inference thinking on your part! What you say makes sense. Please note: My headset is I'm just hoping the Colon Cancer thingie comes out on time and somebody KNOWS how to get it in the right distribution channels. To my simple knowledge there is no equivalent competitor for this product. And a fair size need for it. If I've got it wrong - please yell. Regards, John McCarthy